Enteroporc Coli
Neonatal piglet colibacillosis vaccine (recombinant, inactivated)
Table of contents
Overview
Enteroporc Coli is a veterinary vaccine given to sows (female pigs that have already given birth to piglets) or gilts (female pigs that have not yet given birth to piglets) to protect their offspring from intestinal disease caused by Escherichia coli (E. coli). It contains parts of the E. coli bacterium called fimbrial adhesins F4ab, F4ac, F5 and F6.
Authorisation details
Product details | |
---|---|
Name |
Enteroporc Coli
|
Agency product number |
EMEA/V/C/005148
|
Active substance |
|
International non-proprietary name (INN) or common name |
Neonatal piglet colibacillosis vaccine (recombinant, inactivated)
|
Species |
Pigs
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QI09AB02
|
Publication details | |
---|---|
Marketing-authorisation holder |
CEVA Santé Animale
|
Revision |
1
|
Date of issue of marketing authorisation valid throughout the European Union |
06/01/2021
|
Contact address |
10 avenue de La Ballastière |
Product information
26/04/2021 Enteroporc Coli - EMEA/V/C/005148 - T/0001
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
Immunologicals for suidae
Therapeutic indication
For the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce clinical signs (severe diarrhoea) and mortality caused by Escherichia coli strains expressing the fimbrial adhesins F4ab, F4ac, F5 and F6.